Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rapid and In-Depth Coverage of the (Phospho-)Proteome With Deep Libraries and Optimal Window Design for dia-PASEF. | Mol Cell Proteomics | 2022 | 35944843 | PubTator, text mining | PubMed |
| A Brief Overview on BDNF-Trk Pathway in the Nervous System: A Potential Biomarker or Possible Target in Treatment of Multiple Sclerosis? | Front Neurol | 2022 | 35911894 | PubTator, text mining | PubMed |
| High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition. | Cell Rep | 2022 | 35905710 | PubTator, text mining | PubMed |
| The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients. | Front Genet | 2022 | 35903358 | PubTator, text mining | PubMed |
| Case Report: Primary Leptomeningeal Medulloblastoma in a Child: Clinical Case Report and Literature Review. | Front Pediatr | 2022 | 35899134 | PubTator, text mining | PubMed |
| Hsa_circ_0079530/AQP4 Axis Is Related to Non-Small Cell Lung Cancer Development and Radiosensitivity. | Ann Thorac Cardiovasc Surg | 2022 | 35896371 | PubTator, text mining | PubMed |
| Interference of PTK6/GAB1 signaling inhibits cell proliferation, invasion, and migration of cervical cancer cells. | Mol Med Rep | 2022 | 35894144 | PubTator, text mining | PubMed |
| Folding and Binding Mechanisms of the SH2 Domain from Crkl. | Biomolecules | 2022 | 35892324 | PubTator, text mining | PubMed |
| Link between Insulin Resistance and Obesity-From Diagnosis to Treatment. | Diagnostics (Basel) | 2022 | 35885586 | PubTator, text mining | PubMed |
| Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR-Activating Mutation. | Cells | 2022 | 35883645 | PubTator, text mining | PubMed |
| Developmental Cues and Molecular Drivers in Myelinogenesis: Revisiting Early Life to Re-Evaluate the Integrity of CNS Myelin. | Curr Issues Mol Biol | 2022 | 35877446 | PubTator, text mining | PubMed |
| Circ_0057452 sponges miR-7-5p to promote keloid progression through upregulating GAB1. | Cell Cycle | 2022 | 35876480 | PubTator, text mining | PubMed |
| Her2/EGFR-PDGFR pathway aberrations associated with tamoxifen response in metastatic breast cancer patients. | J Egypt Natl Canc Inst | 2022 | 35871690 | PubTator, text mining | PubMed |
| Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB. | EMBO J | 2022 | 35844135 | PubTator, text mining | PubMed |
| Angiofibroma of Soft Tissue: A Clinicopathological Study of Eight Cases With Emphasis on the Diagnostic Utility of Fluorescence In Situ Hybridization Detection for NCOA2 Rearrangement. | Front Oncol | 2022 | 35832542 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Prognostic Value and Immune Infiltration of IGFBP Family Members in Glioblastoma. | J Healthc Eng | 2022 | 35832140 | PubTator, text mining | PubMed |
| Dissecting protein tyrosine phosphatase signaling by engineered chemogenetic control of its activity. | J Cell Biol | 2022 | 35829702 | PubTator, text mining | PubMed |
| A pan-cancer analysis confirms PTPN11's potential as a prognostic and immunological biomarker. | Aging (Albany NY) | 2022 | 35802774 | PubTator, text mining | PubMed |
| The relative binding position of Nck and Grb2 adaptors impacts actin-based motility of Vaccinia virus. | Elife | 2022 | 35796545 | PubTator, text mining | PubMed |
| A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection. | Sci Rep | 2022 | 35794133 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=20